Literature DB >> 9575199

High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14.

M J Hunter1, W J Chazin.   

Abstract

The phenotypical and functional heterogeneity of different macrophage subpopulations are defined by discrete changes in the expression of two S100 calcium-binding proteins, migration inhibitory factor-related proteins (MRPs) 8 and 14. To further our understanding of MRP8 and MRP14 in the developmental stages of inflammatory responses, overexpression of the MRPs was obtained through a combination of a T7-based expression vector and the Escherichia coli BL21 (DE3) cell line. An efficient, two-step chromatographic protocol was then developed for rapid, facile purification. Extensive biophysical characterization and chemical cross-linking experiments show that MRP8 and MRP14 form oligomers with a strong preference to associate as a heterodimer. Heteronuclear NMR experiments indicate that a specific well packed dimer is formed only in equimolar mixtures of the two proteins. Our results suggest that there is a unique complementarity in the interface of the MRP8/MRP14 complex that cannot be fully reproduced in the MRP8 and MRP14 homodimers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575199     DOI: 10.1074/jbc.273.20.12427

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Conformational and thermodynamic properties of peptide binding to the human S100P protein.

Authors:  Alexey V Gribenko; Mercedes Guzmán-Casado; Maria M Lopez; George I Makhatadze
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Viviane Z Rocha; Eduardo J Folco; Rica Shubiki; Nir Grabie; Sunyoung Jang; Andrew H Lichtman; Ayako Shimizu; Nancy Hogg; Daniel I Simon; Richard N Mitchell; Kevin Croce
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

3.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

4.  Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

Authors:  T Kaiser; J Langhorst; H Wittkowski; K Becker; A W Friedrich; A Rueffer; G J Dobos; J Roth; D Foell
Journal:  Gut       Date:  2007-08-03       Impact factor: 23.059

5.  S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins.

Authors:  Nadia Anceriz; Karen Vandal; Philippe A Tessier
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

6.  Initial Biochemical and Functional Evaluation of Murine Calprotectin Reveals Ca(II)-Dependence and Its Ability to Chelate Multiple Nutrient Transition Metal Ions.

Authors:  Rose C Hadley; Yu Gu; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2018-05-02       Impact factor: 3.162

7.  Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.

Authors:  Pratima Sinha; Chinonyerem Okoro; Dirk Foell; Hudson H Freeze; Suzanne Ostrand-Rosenberg; Geetha Srikrishna
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

8.  Relating form and function of EF-hand calcium binding proteins.

Authors:  Walter J Chazin
Journal:  Acc Chem Res       Date:  2011-02-11       Impact factor: 22.384

9.  Myeloid cell function in MRP-14 (S100A9) null mice.

Authors:  Josie A R Hobbs; Richard May; Kiki Tanousis; Eileen McNeill; Margaret Mathies; Christoffer Gebhardt; Robert Henderson; Matthew J Robinson; Nancy Hogg
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  A new approach to discovery of S100 protein heterodimers.

Authors:  Velia Garcia; Walter J Chazin
Journal:  FEBS J       Date:  2019-05-03       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.